Jan. 11, 2012
/PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude® SkinPrep System for transdermal drug delivery, today announced that
Patrick T. Mooney
, M.D., Chairman & CEO of Echo Therapeutics, will present at Noble Financial Capital Markets' Eighth Annual Equity Conference.
Dr. Mooney will make a presentation to prospective corporate partners and investors on
Tuesday, January 17th
12:30 PM ET
. The Company's presentation will be delivered at the Hard Rock Hotel in
At the time of the presentation, a live audio and high-definition video webcast of Echo Therapeutics' presentation and a copy of the presentation materials will be available on the Company's website
on the Events page or through the Noble Financial websites:
. Echo Therapeutics recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. A Microsoft SilverLight viewer (a free download from the presentation link) is required to participate. The webcast and presentation will also be archived on
for 30 days following the event.
About Echo Therapeutics
Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System as a platform technology for enhanced skin permeation for delivery of topical pharmaceuticals.
For More Information:
Christine Olimpio Director, Investor Relations & Corporate Communications (215) 717-4104
Connect With Us:
- Visit our website at
- Follow us on Twitter at
- Join us on Facebook at